1-6 of 6
Michael E.J. Lean
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Time Course of Normalization of Functional β-Cell Capacity in the Diabetes Remission Clinical Trial After Weight Loss in Type 2 Diabetes

Sviatlana V. Zhyzhneuskaya, Ahmad Al-Mrabeh, Carl Peters, Alison Barnes, Benjamin Aribisala, Kieren G. Hollingsworth, Alex McConnachie, Naveed Sattar, Michael E.J. Lean, Roy Taylor
Journal: Diabetes Care
Diabetes Care 2020;43(4):813–820
https://doi.org/10.2337/dc19-0371
Published: 14 February 2020
View article titled, Time Course of Normalization of Functional β-Cell Capacity in the Diabetes Remission Clinical Trial After Weight Loss in Type 2 Diabetes
Open the PDF for Time Course of Normalization of Functional β-Cell Capacity in the Diabetes Remission Clinical Trial After Weight Loss in Type 2 Diabetes in another window
Includes: Supplementary data
Journal Articles

Sitting Time and Waist Circumference Are Associated With Glycemia in U.K. South Asians: Data from 1,228 adults screened for the PODOSA trial

Jason M.R. Gill, PHD, Raj Bhopal, MB, CHB, MD, DSC, Anne Douglas, MA, Sunita Wallia, MSC, Ruby Bhopal, BSC, Aziz Sheikh, MB, BS, MD, John F. Forbes, PHD, John McKnight, MB, BCH, MD, Naveed Sattar, MB, CHB, PHD, Gordon Murray, PHD, Michael E.J. Lean, MB, BCHIR, MD, Sarah H. Wild, MB, BCHIR, PHD
Journal: Diabetes Care
Diabetes Care 2011;34(5):1214–1218
https://doi.org/10.2337/dc10-2313
Published: 20 April 2011
View article titled, Sitting Time and Waist Circumference Are Associated With Glycemia in U.K. South Asians: <subtitle>Data from 1,228 adults screened for the PODOSA trial</subtitle>
Open the PDF for Sitting Time and Waist Circumference Are Associated With Glycemia in U.K. South Asians: <subtitle>Data from 1,228 adults screened for the PODOSA trial</subtitle> in another window
Journal Articles

Patients on Atypical Antipsychotic Drugs: Another High-Risk Group for Type 2 Diabetes: Response to Hardy and Breier

Michael E.J. Lean, MA, MB, BCHIR, MD, FRCP, Frank-Gerald Pajonk, MD
Journal: Diabetes Care
Diabetes Care 2003;26(11):3202–3203
https://doi.org/10.2337/diacare.26.11.3202
Published: 01 November 2003
View article titled, Patients on Atypical Antipsychotic Drugs: Another High-Risk Group for Type 2 Diabetes: <subtitle>Response to Hardy and Breier</subtitle>
Open the PDF for Patients on Atypical Antipsychotic Drugs: Another High-Risk Group for Type 2 Diabetes: <subtitle>Response to Hardy and Breier</subtitle> in another window
Journal Articles

Patients on Atypical Antipsychotic Drugs: Another high-risk group for type 2 diabetes

Michael E.J. Lean, MA, MB, BCHIR, MD, FRCP, Frank-Gerald Pajonk, MD
Journal: Diabetes Care
Diabetes Care 2003;26(5):1597–1605
https://doi.org/10.2337/diacare.26.5.1597
Published: 01 May 2003
View article titled, Patients on Atypical Antipsychotic Drugs: <subtitle>Another high-risk group for type 2 diabetes </subtitle>
Open the PDF for Patients on Atypical Antipsychotic Drugs: <subtitle>Another high-risk group for type 2 diabetes </subtitle> in another window
Journal Articles

Prospective Relation of C-Reactive Protein With Type 2 Diabetes: Response to Snijder et al.

Naveed Sattar, MD, PHD, Ken Williams, MS, Thang S. Han, MD, PHD, Clicerio Gonzalez-Villalpando, MD, Michael E.J. Lean, MD, FRCP, Steven M. Haffner, MD, MPH
Journal: Diabetes Care
Diabetes Care 2003;26(5):1657–1658
https://doi.org/10.2337/diacare.26.5.1657
Published: 01 May 2003
View article titled, Prospective Relation of C-Reactive Protein With Type 2 Diabetes: <subtitle>Response to Snijder et al. </subtitle>
Open the PDF for Prospective Relation of C-Reactive Protein With Type 2 Diabetes: <subtitle>Response to Snijder et al. </subtitle> in another window
Journal Articles

Prospective Study of C-Reactive Protein in Relation to the Development of Diabetes and Metabolic Syndrome in the Mexico City Diabetes Study

Thang S. Han, MD, PHD, Naveed Sattar, MD, PHD, Ken Williams, MS, Clicerio Gonzalez-Villalpando, MD, Michael E.J. Lean, MD, FRCP, Steven M. Haffner, MD, MPH
Journal: Diabetes Care
Diabetes Care 2002;25(11):2016–2021
https://doi.org/10.2337/diacare.25.11.2016
Published: 01 November 2002
View article titled, Prospective Study of C-Reactive Protein in Relation to the Development of Diabetes and Metabolic Syndrome in the Mexico City Diabetes Study
Open the PDF for Prospective Study of C-Reactive Protein in Relation to the Development of Diabetes and Metabolic Syndrome in the Mexico City Diabetes Study in another window